Enabling Novel CRISPR-Cas9 Delivery: Custom Protein Manufacturing
Download Case Study
| region | na1 |
| portalId | 1769030 |
| formId | 7d08e288-b33f-4e1c-bd5d-251262db95f1 |
| target | services-hubspot-form |
| redirectUrl | https://www.aldevron.com/thank-you/enabling-novel-crispr-cas9-delivery |
When it comes to protein manufacturing, projects are as unique as our client’s aspirations. The challenges, from construct design through analytical testing, are equally unique. To bring your therapeutic proteins to life, your CDMO partner must offer a combination of experience and capabilities to fulfill your specific requirements.
In July 2022, Dr. Jennifer Doudna, Dr. Elizabeth Stahl and the team at the Innovative Genomics Institute approached Aldevron with a challenge to manufacture a custom, ultra-low endo toxin nuclease. Read our Case Study for details on their demanding request and the results.
Learn how we are supporting the study of injection-based delivery of CRISPR-Cas9 ribonucleoproteins (RNPs)* for central nervous system disorders.
Download our case study today.
*Aldevron provides RNPs only to customers who are duly licensed, including to make and have made RNPs, for their intended use.